speb/financial-data huggingface dataset:
NHS balance_sheet (annual, 2024-10-31) — Other Payable: 405156.00
NHS balance_sheet (quarterly, 2024-10-31) — Other Payable: 405156.00
NHS balance_sheet (annual, 2024-10-31) — Payables: 5769403.00
NHS balance_sheet (quarterly, 2024-10-31) — Payables: 5769403.00
NHS balance_sheet (annual, 2024-10-31) — Preferred Securities Outside Stock Equity: 39955483.00
NHS balance_sheet (quarterly, 2024-10-31) — Preferred Securities Outside Stock Equity: 39955483.00
NHS balance_sheet (annual, 2024-10-31) — Prepaid Assets: 129410.00
NHS balance_sheet (quarterly, 2024-10-31) — Prepaid Assets: 129410.00
NHS income_statement (annual, 2024-10-31) — Pretax Income: 37939889.00
NHS balance_sheet (annual, 2024-10-31) — Receivables: 5765441.00
NHS balance_sheet (quarterly, 2024-10-31) — Receivables: 5765441.00
NHS cash_flow (annual, 2024-10-31) — Repayment Of Debt: -50500000.00
NHS balance_sheet (annual, 2024-10-31) — Retained Earnings: -51921242.00
NHS balance_sheet (quarterly, 2024-10-31) — Retained Earnings: -51921242.00
NHS income_statement (annual, 2024-10-31) — Selling General And Administration: 949925.00
NHS balance_sheet (annual, 2024-10-31) — Share Issued: 29916986.00
NHS balance_sheet (quarterly, 2024-10-31) — Share Issued: 29916986.00
NHS balance_sheet (annual, 2024-10-31) — Stockholders Equity: 234140262.00
NHS balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: 234140262.00
NHS balance_sheet (annual, 2024-10-31) — Tangible Book Value: 234140262.00
NHS balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: 234140262.00
NHS income_statement (annual, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
NHS income_statement (annual, 2024-10-31) — Tax Rate For Calcs: 0.21
NHS balance_sheet (annual, 2024-10-31) — Total Assets: 323576343.00
NHS balance_sheet (quarterly, 2024-10-31) — Total Assets: 323576343.00
NHS balance_sheet (annual, 2024-10-31) — Total Capitalization: 277640262.00
NHS balance_sheet (quarterly, 2024-10-31) — Total Capitalization: 277640262.00
NHS balance_sheet (annual, 2024-10-31) — Total Debt: 43500000.00
NHS balance_sheet (quarterly, 2024-10-31) — Total Debt: 43500000.00
NHS balance_sheet (annual, 2024-10-31) — Total Equity Gross Minority Interest: 234140262.00
NHS balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: 234140262.00
NHS balance_sheet (annual, 2024-10-31) — Total Liabilities Net Minority Interest: 89436081.00
NHS balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 89436081.00
NHS balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 2702137.00
NHS balance_sheet (quarterly, 2025-04-30) — Available For Sale Securities: 3307201.00
NHS balance_sheet (quarterly, 2025-04-30) — Capital Stock: 292900113.00
NHS balance_sheet (quarterly, 2025-04-30) — Common Stock: 292900113.00
NHS balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 227934148.00
NHS balance_sheet (quarterly, 2025-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 314132580.00
NHS balance_sheet (quarterly, 2025-04-30) — Invested Capital: 281434148.00
NHS balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 317439781.00
NHS balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 317439781.00
NHS balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 53500000.00
NHS balance_sheet (quarterly, 2025-04-30) — Net Debt: 53500000.00
NHS balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 227934148.00
NHS balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 30814868.00
NHS balance_sheet (quarterly, 2025-04-30) — Other Payable: 843035.00
NHS balance_sheet (quarterly, 2025-04-30) — Payables: 3545172.00
NHS balance_sheet (quarterly, 2025-04-30) — Preferred Securities Outside Stock Equity: 39967044.00
NHS balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 269891.00
NHS balance_sheet (quarterly, 2025-04-30) — Receivables: 7364508.00
NHS balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -64965965.00
NHS balance_sheet (quarterly, 2025-04-30) — Share Issued: 30814868.00
NHS balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 227934148.00
NHS balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 227934148.00
NHS balance_sheet (quarterly, 2025-04-30) — Total Assets: 325079760.00
NHS balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 281434148.00
NHS balance_sheet (quarterly, 2025-04-30) — Total Debt: 53500000.00
NHS balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 227934148.00
NHS balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 97145612.00
NHS income_statement (annual, 2025-10-31) — +Operating Expense: 3231974.00
NHS income_statement (annual, 2025-10-31) — +Total Revenue: 23448066.00
NHS balance_sheet (annual, 2025-10-31) — Accounts Payable: 5144075.00
NHS balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 5144075.00
NHS balance_sheet (annual, 2025-10-31) — Available For Sale Securities: 11600858.00
NHS balance_sheet (quarterly, 2025-10-31) — Available For Sale Securities: 11600858.00
NHS income_statement (annual, 2025-10-31) — Basic Average Shares: 30804150.00
NHS income_statement (annual, 2025-10-31) — Basic EPS: 0.66
NHS cash_flow (annual, 2025-10-31) — Beginning Cash Position: -223129.00
NHS balance_sheet (annual, 2025-10-31) — Capital Stock: 280415952.00
NHS balance_sheet (quarterly, 2025-10-31) — Capital Stock: 280415952.00
NHS cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -32917701.00
NHS cash_flow (annual, 2025-10-31) — Change In Accrued Expense: -46898.00
NHS cash_flow (annual, 2025-10-31) — Change In Other Current Liabilities: 23313.00
NHS cash_flow (annual, 2025-10-31) — Change In Payable: -348051.00
NHS cash_flow (annual, 2025-10-31) — Change In Prepaid Assets: -218459.00
NHS cash_flow (annual, 2025-10-31) — Change In Receivables: 177366.00
NHS cash_flow (annual, 2025-10-31) — Change In Working Capital: -412729.00
NHS cash_flow (annual, 2025-10-31) — Changes In Cash: 21751.00
NHS balance_sheet (annual, 2025-10-31) — Common Stock: 280415952.00
NHS balance_sheet (quarterly, 2025-10-31) — Common Stock: 280415952.00
NHS cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -32917701.00
NHS balance_sheet (annual, 2025-10-31) — Common Stock Equity: 233289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 233289950.00
NHS cash_flow (annual, 2025-10-31) — Common Stock Issuance: 11817925.00
NHS income_statement (annual, 2025-10-31) — Diluted Average Shares: 30804150.00
NHS income_statement (annual, 2025-10-31) — Diluted EPS: 0.66
NHS income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 20216092.00
NHS cash_flow (annual, 2025-10-31) — End Cash Position: -201378.00
NHS balance_sheet (annual, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 322241109.00
NHS balance_sheet (quarterly, 2025-10-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 322241109.00
NHS cash_flow (annual, 2025-10-31) — Financing Cash Flow: -3599776.00
NHS cash_flow (annual, 2025-10-31) — Free Cash Flow: 3621527.00
NHS cash_flow (annual, 2025-10-31) — Gain Loss On Investment Securities: -14847351.00
NHS income_statement (annual, 2025-10-31) — Gain On Sale Of Security: 3432940.00
NHS income_statement (annual, 2025-10-31) — General And Administrative Expense: 751522.00
NHS income_statement (annual, 2025-10-31) — Interest Expense: 2744453.00
NHS income_statement (annual, 2025-10-31) — Interest Income: 23260766.00
NHS balance_sheet (annual, 2025-10-31) — Invested Capital: 294289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Invested Capital: 294289950.00
NHS balance_sheet (annual, 2025-10-31) — Investmentin Financial Assets: 333841967.00
NHS balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 333841967.00
NHS balance_sheet (annual, 2025-10-31) — Investments And Advances: 333841967.00
NHS balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 333841967.00
NHS cash_flow (annual, 2025-10-31) — Issuance Of Capital Stock: 11817925.00
NHS cash_flow (annual, 2025-10-31) — Issuance Of Debt: 29500000.00
NHS balance_sheet (annual, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 61000000.00
NHS balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 61000000.00
NHS cash_flow (annual, 2025-10-31) — Long Term Debt Issuance: 29500000.00
NHS cash_flow (annual, 2025-10-31) — Long Term Debt Payments: -12000000.00
NHS cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: 11817925.00
NHS balance_sheet (annual, 2025-10-31) — Net Debt: 61000000.00
NHS balance_sheet (quarterly, 2025-10-31) — Net Debt: 61000000.00
NHS income_statement (annual, 2025-10-31) — Net Income: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 20216092.00
NHS cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 20216092.00
NHS income_statement (annual, 2025-10-31) — Net Interest Income: 20516313.00
NHS cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: 17500000.00
NHS cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: 17500000.00
NHS cash_flow (annual, 2025-10-31) — Net Other Financing Charges: 0.00
NHS balance_sheet (annual, 2025-10-31) — Net Tangible Assets: 233289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 233289950.00
NHS income_statement (annual, 2025-10-31) — Normalized Income: 20216092.00
NHS cash_flow (annual, 2025-10-31) — Operating Cash Flow: 3621527.00
NHS income_statement (annual, 2025-10-31) — Operating Revenue: 23448066.00
NHS balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 31526500.00
NHS balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 31526500.00
NHS cash_flow (annual, 2025-10-31) — Other Non Cash Items: -1334485.00
NHS income_statement (annual, 2025-10-31) — Other Operating Expenses: 2480452.00
NHS balance_sheet (annual, 2025-10-31) — Other Payable: 221149.00
NHS balance_sheet (quarterly, 2025-10-31) — Other Payable: 221149.00
NHS balance_sheet (annual, 2025-10-31) — Payables: 5365224.00
NHS balance_sheet (quarterly, 2025-10-31) — Payables: 5365224.00
NHS balance_sheet (annual, 2025-10-31) — Preferred Securities Outside Stock Equity: 39978796.00
NHS balance_sheet (quarterly, 2025-10-31) — Preferred Securities Outside Stock Equity: 39978796.00
NHS balance_sheet (annual, 2025-10-31) — Prepaid Assets: 344164.00
NHS balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 344164.00
NHS income_statement (annual, 2025-10-31) — Pretax Income: 20216092.00
NHS balance_sheet (annual, 2025-10-31) — Receivables: 5587070.00
NHS balance_sheet (quarterly, 2025-10-31) — Receivables: 5587070.00
NHS cash_flow (annual, 2025-10-31) — Repayment Of Debt: -12000000.00
NHS balance_sheet (annual, 2025-10-31) — Retained Earnings: -47126002.00
NHS balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -47126002.00
NHS income_statement (annual, 2025-10-31) — Selling General And Administration: 751522.00
NHS balance_sheet (annual, 2025-10-31) — Share Issued: 31526500.00
NHS balance_sheet (quarterly, 2025-10-31) — Share Issued: 31526500.00
NHS balance_sheet (annual, 2025-10-31) — Stockholders Equity: 233289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 233289950.00
NHS balance_sheet (annual, 2025-10-31) — Tangible Book Value: 233289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 233289950.00
NHS income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: 0.00
NHS income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.21
NHS balance_sheet (annual, 2025-10-31) — Total Assets: 339798267.00
NHS balance_sheet (quarterly, 2025-10-31) — Total Assets: 339798267.00
NHS balance_sheet (annual, 2025-10-31) — Total Capitalization: 294289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 294289950.00
NHS balance_sheet (annual, 2025-10-31) — Total Debt: 61000000.00
NHS balance_sheet (quarterly, 2025-10-31) — Total Debt: 61000000.00
NHS balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 233289950.00
NHS balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 233289950.00
NHS balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 106508317.00
NHS balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 106508317.00
NHS balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 8232481.00
NHS balance_sheet (quarterly, 2026-04-30) — Available For Sale Securities: 4577007.00
NHS balance_sheet (quarterly, 2026-04-30) — Capital Stock: 345600992.00
NHS balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 7.00
NHS balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Federal Funds Sold: 7.00
NHS balance_sheet (quarterly, 2026-04-30) — Cash Financial: 7.00
NHS balance_sheet (quarterly, 2026-04-30) — Common Stock: 345600992.00
NHS balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 285454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 412006303.00
NHS balance_sheet (quarterly, 2026-04-30) — Invested Capital: 379454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Investmentin Financial Assets: 416583310.00
NHS balance_sheet (quarterly, 2026-04-30) — Investments And Advances: 416583310.00
NHS balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 94000000.00
NHS balance_sheet (quarterly, 2026-04-30) — Net Debt: 93999993.00
NHS balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 285454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 41855793.00
NHS balance_sheet (quarterly, 2026-04-30) — Other Payable: 901438.00
NHS balance_sheet (quarterly, 2026-04-30) — Payables: 9133919.00
NHS balance_sheet (quarterly, 2026-04-30) — Preferred Securities Outside Stock Equity: 39990356.00
NHS balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 322301.00
NHS balance_sheet (quarterly, 2026-04-30) — Receivables: 11810837.00
NHS balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -60146554.00
NHS balance_sheet (quarterly, 2026-04-30) — Share Issued: 41855793.00
NHS balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 285454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 285454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Total Assets: 428722499.00
NHS balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 379454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Total Debt: 94000000.00
NHS balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 285454438.00
NHS balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 143268061.00
NHTC balance_sheet (annual, 2021-12-31) — Construction In Progress: 173000.00
NHTC cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1865000.00
NHTC balance_sheet (annual, 2021-12-31) — Inventories Adjustments Allowances: -92000.00
NHTC balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 12130000.00
NHTC income_statement (annual, 2022-12-31) — +Operating Expense: 36743000.00
NHTC income_statement (annual, 2022-12-31) — +Total Revenue: 49134000.00
NHTC balance_sheet (annual, 2022-12-31) — Accounts Payable: 810000.00
NHTC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2334000.00
NHTC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 86102000.00
NHTC income_statement (annual, 2022-12-31) — Basic Average Shares: 11362000.00
NHTC income_statement (annual, 2022-12-31) — Basic EPS: 0.03
NHTC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 84365000.00
NHTC balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 3992000.00
NHTC cash_flow (annual, 2022-12-31) — Capital Expenditure: -143000.00
NHTC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4124000.00
NHTC balance_sheet (annual, 2022-12-31) — Capital Stock: 13000.00
NHTC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 69667000.00
NHTC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 69667000.00
NHTC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -9138000.00
NHTC balance_sheet (annual, 2022-12-31) — Cash Equivalents: 56833000.00
NHTC balance_sheet (annual, 2022-12-31) — Cash Financial: 12834000.00
NHTC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -9138000.00
NHTC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -143000.00
NHTC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -4852000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Account Payable: 52000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -1386000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -1404000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Inventory: 680000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 925000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -2597000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2901000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Payable: -1352000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -2738000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Tax Payable: -1404000.00
NHTC cash_flow (annual, 2022-12-31) — Change In Working Capital: -6631000.00
NHTC cash_flow (annual, 2022-12-31) — Changes In Cash: -14133000.00
NHTC balance_sheet (annual, 2022-12-31) — Common Stock: 13000.00
NHTC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -9138000.00
NHTC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 50151000.00
NHTC balance_sheet (annual, 2022-12-31) — Construction In Progress: 30000.00
NHTC income_statement (annual, 2022-12-31) — Cost Of Revenue: 12661000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3317000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Assets: 77551000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1135000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1135000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 5597000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 5597000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Liabilities: 20438000.00
NHTC balance_sheet (annual, 2022-12-31) — Current Provisions: 70000.00
NHTC cash_flow (annual, 2022-12-31) — Deferred Income Tax: 90000.00
NHTC cash_flow (annual, 2022-12-31) — Deferred Tax: 90000.00
NHTC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 204000.00
NHTC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 204000.00
NHTC income_statement (annual, 2022-12-31) — Diluted Average Shares: 11423000.00
NHTC income_statement (annual, 2022-12-31) — Diluted EPS: 0.03
NHTC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 313000.00
NHTC income_statement (annual, 2022-12-31) — EBIT: -270000.00
NHTC income_statement (annual, 2022-12-31) — EBITDA: -66000.00
NHTC cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -486000.00
NHTC cash_flow (annual, 2022-12-31) — End Cash Position: 69746000.00
NHTC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -9138000.00
NHTC balance_sheet (annual, 2022-12-31) — Finished Goods: 3653000.00
NHTC cash_flow (annual, 2022-12-31) — Free Cash Flow: -4995000.00
NHTC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1004000.00
NHTC income_statement (annual, 2022-12-31) — General And Administrative Expense: 15996000.00
NHTC balance_sheet (annual, 2022-12-31) — Gross PPE: 6720000.00
NHTC income_statement (annual, 2022-12-31) — Gross Profit: 36473000.00
NHTC cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1662000.00
NHTC balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2972000.00
NHTC balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -18000.00
NHTC balance_sheet (annual, 2022-12-31) — Inventory: 4525000.00
NHTC balance_sheet (annual, 2022-12-31) — Invested Capital: 50151000.00
NHTC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -143000.00
NHTC balance_sheet (annual, 2022-12-31) — Leases: 981000.00
NHTC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2989000.00
NHTC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2989000.00
NHTC balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1717000.00
NHTC income_statement (annual, 2022-12-31) — Net Income: 313000.00
NHTC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 313000.00
NHTC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 313000.00
NHTC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 313000.00
NHTC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 313000.00
NHTC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 313000.00
NHTC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 313000.00
NHTC balance_sheet (annual, 2022-12-31) — Net PPE: 4386000.00
NHTC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -143000.00
NHTC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 50151000.00
NHTC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 195000.00
NHTC balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 141000.00
NHTC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 195000.00
NHTC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 141000.00
NHTC income_statement (annual, 2022-12-31) — Normalized EBITDA: -66000.00
NHTC income_statement (annual, 2022-12-31) — Normalized Income: 313000.00
NHTC cash_flow (annual, 2022-12-31) — Operating Cash Flow: -4852000.00
NHTC income_statement (annual, 2022-12-31) — Operating Income: -270000.00
NHTC income_statement (annual, 2022-12-31) — Operating Revenue: 49352000.00
NHTC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 11422539.00
NHTC balance_sheet (annual, 2022-12-31) — Other Current Assets: 3359000.00
NHTC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 5800000.00
NHTC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1004000.00
NHTC income_statement (annual, 2022-12-31) — Other Gand A: 15996000.00
NHTC income_statement (annual, 2022-12-31) — Other Income Expense: 872000.00
NHTC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1172000.00
NHTC balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 685000.00
NHTC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 872000.00
NHTC balance_sheet (annual, 2022-12-31) — Payables: 3782000.00
NHTC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 7099000.00
NHTC balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 737000.00
NHTC balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
NHTC income_statement (annual, 2022-12-31) — Pretax Income: 602000.00
NHTC balance_sheet (annual, 2022-12-31) — Properties: 0.00
NHTC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -143000.00
NHTC balance_sheet (annual, 2022-12-31) — Raw Materials: 890000.00
NHTC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 12661000.00
NHTC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 204000.00
NHTC balance_sheet (annual, 2022-12-31) — Retained Earnings: -9056000.00
NHTC income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 20747000.00
NHTC income_statement (annual, 2022-12-31) — Selling General And Administration: 36743000.00
NHTC balance_sheet (annual, 2022-12-31) — Share Issued: 12979414.00
NHTC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
NHTC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 50151000.00
NHTC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 50151000.00
NHTC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
NHTC income_statement (annual, 2022-12-31) — Tax Provision: 289000.00
NHTC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
NHTC balance_sheet (annual, 2022-12-31) — Total Assets: 82817000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Capitalization: 50151000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Debt: 4124000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 50151000.00
NHTC income_statement (annual, 2022-12-31) — Total Expenses: 49404000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 32666000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5266000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 12228000.00
NHTC income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -270000.00
NHTC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2972000.00
NHTC balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 9098000.00
NHTC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 1556875.00
NHTC balance_sheet (annual, 2022-12-31) — Treasury Stock: 25904000.00
NHTC balance_sheet (annual, 2022-12-31) — Working Capital: 57113000.00
NHTC income_statement (annual, 2023-12-31) — +Operating Expense: 34420000.00
NHTC income_statement (annual, 2023-12-31) — +Total Revenue: 43924000.00
NHTC balance_sheet (annual, 2023-12-31) — Accounts Payable: 990000.00
NHTC balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2212000.00
NHTC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 84695000.00
NHTC cash_flow (annual, 2023-12-31) — Amortization Of Securities: 0.00
NHTC income_statement (annual, 2023-12-31) — Basic Average Shares: 11436000.00
NHTC income_statement (annual, 2023-12-31) — Basic EPS: 0.05
NHTC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 69746000.00
NHTC balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 3319000.00
NHTC cash_flow (annual, 2023-12-31) — Capital Expenditure: -46000.00
NHTC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3464000.00
NHTC balance_sheet (annual, 2023-12-31) — Capital Stock: 13000.00
NHTC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 56178000.00
NHTC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 56178000.00
NHTC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -9215000.00
NHTC balance_sheet (annual, 2023-12-31) — Cash Equivalents: 47207000.00
NHTC balance_sheet (annual, 2023-12-31) — Cash Financial: 8971000.00
NHTC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -9215000.00
NHTC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -46000.00
NHTC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -4278000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Account Payable: 181000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -870000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -3299000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Inventory: 228000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -722000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -2185000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 565000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Payable: -3118000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3988000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Tax Payable: -3299000.00
NHTC cash_flow (annual, 2023-12-31) — Change In Working Capital: -6102000.00
NHTC cash_flow (annual, 2023-12-31) — Changes In Cash: -13539000.00
NHTC balance_sheet (annual, 2023-12-31) — Common Stock: 13000.00
NHTC cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -9215000.00
NHTC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 41600000.00
NHTC balance_sheet (annual, 2023-12-31) — Construction In Progress: 40000.00
NHTC income_statement (annual, 2023-12-31) — Cost Of Revenue: 11175000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2488000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Assets: 64229000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1146000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1146000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 6166000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 6166000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Liabilities: 19984000.00
NHTC balance_sheet (annual, 2023-12-31) — Current Provisions: 81000.00
NHTC cash_flow (annual, 2023-12-31) — Deferred Income Tax: -178000.00
NHTC cash_flow (annual, 2023-12-31) — Deferred Tax: -178000.00
NHTC cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 164000.00
NHTC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 164000.00
NHTC income_statement (annual, 2023-12-31) — Diluted Average Shares: 11456000.00
NHTC income_statement (annual, 2023-12-31) — Diluted EPS: 0.05
NHTC income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 568000.00
NHTC income_statement (annual, 2023-12-31) — EBIT: -1671000.00
NHTC income_statement (annual, 2023-12-31) — EBITDA: -1507000.00
NHTC cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 10000.00
NHTC cash_flow (annual, 2023-12-31) — End Cash Position: 56217000.00
NHTC cash_flow (annual, 2023-12-31) — Financing Cash Flow: -9215000.00
NHTC balance_sheet (annual, 2023-12-31) — Finished Goods: 3438000.00
NHTC cash_flow (annual, 2023-12-31) — Free Cash Flow: -4324000.00
NHTC balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1069000.00
NHTC income_statement (annual, 2023-12-31) — General And Administrative Expense: 16006000.00
NHTC balance_sheet (annual, 2023-12-31) — Gross PPE: 5797000.00
NHTC income_statement (annual, 2023-12-31) — Gross Profit: 32749000.00
NHTC cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 3529000.00
NHTC balance_sheet (annual, 2023-12-31) — Income Tax Payable: 3716000.00
NHTC balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -35000.00
NHTC balance_sheet (annual, 2023-12-31) — Inventory: 4293000.00
NHTC balance_sheet (annual, 2023-12-31) — Invested Capital: 41600000.00
NHTC cash_flow (annual, 2023-12-31) — Investing Cash Flow: -46000.00
NHTC balance_sheet (annual, 2023-12-31) — Leases: 760000.00
NHTC balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2318000.00
NHTC balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2318000.00
NHTC balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1678000.00
NHTC income_statement (annual, 2023-12-31) — Net Income: 568000.00
NHTC income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 568000.00
NHTC income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 568000.00
NHTC income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 568000.00
NHTC income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 568000.00
NHTC cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 568000.00
NHTC income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 568000.00
NHTC cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
NHTC balance_sheet (annual, 2023-12-31) — Net PPE: 3585000.00
NHTC cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -46000.00
NHTC balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 41600000.00
NHTC balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 369000.00
NHTC balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 135000.00
NHTC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 369000.00
NHTC balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 135000.00
NHTC income_statement (annual, 2023-12-31) — Normalized EBITDA: -1507000.00
NHTC income_statement (annual, 2023-12-31) — Normalized Income: 568000.00
NHTC cash_flow (annual, 2023-12-31) — Operating Cash Flow: -4278000.00
NHTC income_statement (annual, 2023-12-31) — Operating Income: -1671000.00
NHTC income_statement (annual, 2023-12-31) — Operating Revenue: 44122000.00
NHTC balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 11516773.00
NHTC balance_sheet (annual, 2023-12-31) — Other Current Assets: 3758000.00
NHTC balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 4729000.00
NHTC balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1069000.00
NHTC income_statement (annual, 2023-12-31) — Other Gand A: 16006000.00
NHTC income_statement (annual, 2023-12-31) — Other Income Expense: 2416000.00
NHTC cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1109000.00
NHTC balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 908000.00
NHTC income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2416000.00
NHTC balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
NHTC balance_sheet (annual, 2023-12-31) — Payables: 4706000.00
NHTC balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 7194000.00
NHTC balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 668000.00
NHTC balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
NHTC income_statement (annual, 2023-12-31) — Pretax Income: 745000.00
NHTC balance_sheet (annual, 2023-12-31) — Properties: 0.00
NHTC cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
NHTC cash_flow (annual, 2023-12-31) — Purchase Of PPE: -46000.00
NHTC balance_sheet (annual, 2023-12-31) — Raw Materials: 855000.00
NHTC income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 11175000.00
NHTC income_statement (annual, 2023-12-31) — Reconciled Depreciation: 164000.00
NHTC balance_sheet (annual, 2023-12-31) — Retained Earnings: -17703000.00
NHTC cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
NHTC income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 18414000.00
NHTC income_statement (annual, 2023-12-31) — Selling General And Administration: 34420000.00
NHTC balance_sheet (annual, 2023-12-31) — Share Issued: 12979414.00
NHTC cash_flow (annual, 2023-12-31) — Stock Based Compensation: 161000.00
NHTC balance_sheet (annual, 2023-12-31) — Stockholders Equity: 41600000.00
NHTC balance_sheet (annual, 2023-12-31) — Tangible Book Value: 41600000.00
NHTC income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
NHTC income_statement (annual, 2023-12-31) — Tax Provision: 177000.00
NHTC income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
NHTC balance_sheet (annual, 2023-12-31) — Total Assets: 69091000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Capitalization: 41600000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Debt: 3464000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 41600000.00
NHTC income_statement (annual, 2023-12-31) — Total Expenses: 45595000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27491000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 4862000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7507000.00
NHTC income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -1671000.00
NHTC balance_sheet (annual, 2023-12-31) — Total Tax Payable: 3716000.00
NHTC balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 5054000.00
NHTC balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 1462641.00
NHTC balance_sheet (annual, 2023-12-31) — Treasury Stock: 24336000.00
NHTC balance_sheet (annual, 2023-12-31) — Working Capital: 44245000.00
NHTC balance_sheet (quarterly, 2024-09-30) — Inventories Adjustments Allowances: -20000.00
NHTC balance_sheet (quarterly, 2024-09-30) — Other Properties: 205000.00
NHTC balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 0.00
NHTC income_statement (annual, 2024-12-31) — +Operating Expense: 33084000.00
NHTC income_statement (annual, 2024-12-31) — +Total Revenue: 42963000.00
NHTC balance_sheet (annual, 2024-12-31) — Accounts Payable: 895000.00
NHTC balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2310000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2310000.00
NHTC balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 84901000.00
NHTC cash_flow (annual, 2024-12-31) — Amortization Of Securities: -441000.00
NHTC income_statement (annual, 2024-12-31) — Basic Average Shares: 11467000.00
NHTC income_statement (annual, 2024-12-31) — Basic EPS: 0.05
NHTC cash_flow (annual, 2024-12-31) — Beginning Cash Position: 56217000.00
NHTC balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 2498000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 2498000.00
NHTC cash_flow (annual, 2024-12-31) — Capital Expenditure: -57000.00
NHTC balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2641000.00
NHTC balance_sheet (annual, 2024-12-31) — Capital Stock: 13000.00
NHTC balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 13533000.00
NHTC balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 43940000.00
NHTC cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -9213000.00
NHTC balance_sheet (annual, 2024-12-31) — Cash Equivalents: 5608000.00
NHTC balance_sheet (annual, 2024-12-31) — Cash Financial: 7925000.00
NHTC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -9213000.00
NHTC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -30075000.00
NHTC cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3367000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Account Payable: -94000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 252000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -3862000.00
NHTC cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: -124000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Inventory: 1000000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -534000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1885000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 245000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Payable: -3956000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -3704000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Tax Payable: -3862000.00
NHTC cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: -124000.00
NHTC cash_flow (annual, 2024-12-31) — Change In Working Capital: -4878000.00
NHTC cash_flow (annual, 2024-12-31) — Changes In Cash: -42655000.00
NHTC balance_sheet (annual, 2024-12-31) — Common Stock: 13000.00
NHTC cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -9213000.00
NHTC balance_sheet (annual, 2024-12-31) — Common Stock Equity: 32872000.00
NHTC balance_sheet (annual, 2024-12-31) — Construction In Progress: 0.00
NHTC balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 0.00
NHTC income_statement (annual, 2024-12-31) — Cost Of Revenue: 11178000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2705000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Assets: 50983000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1127000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1127000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 6428000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 6428000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Liabilities: 20799000.00
NHTC balance_sheet (annual, 2024-12-31) — Current Provisions: 85000.00
NHTC cash_flow (annual, 2024-12-31) — Deferred Income Tax: 17000.00
NHTC cash_flow (annual, 2024-12-31) — Deferred Tax: 17000.00
NHTC cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 131000.00
NHTC cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 131000.00
NHTC income_statement (annual, 2024-12-31) — Diluted Average Shares: 11490000.00
NHTC income_statement (annual, 2024-12-31) — Diluted EPS: 0.05
NHTC income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 572000.00
NHTC income_statement (annual, 2024-12-31) — EBIT: -1299000.00
NHTC income_statement (annual, 2024-12-31) — EBITDA: -1168000.00
NHTC cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 5000.00
NHTC cash_flow (annual, 2024-12-31) — End Cash Position: 13567000.00
NHTC cash_flow (annual, 2024-12-31) — Financing Cash Flow: -9213000.00
NHTC balance_sheet (annual, 2024-12-31) — Finished Goods: 2770000.00
NHTC cash_flow (annual, 2024-12-31) — Free Cash Flow: -3424000.00
NHTC balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1301000.00
NHTC income_statement (annual, 2024-12-31) — General And Administrative Expense: 15513000.00
NHTC balance_sheet (annual, 2024-12-31) — Gross PPE: 4998000.00
NHTC income_statement (annual, 2024-12-31) — Gross Profit: 31785000.00
NHTC cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3958000.00
NHTC balance_sheet (annual, 2024-12-31) — Income Tax Payable: 4908000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 4908000.00
NHTC balance_sheet (annual, 2024-12-31) — Inventory: 3272000.00
NHTC balance_sheet (annual, 2024-12-31) — Invested Capital: 32872000.00
NHTC cash_flow (annual, 2024-12-31) — Investing Cash Flow: -30075000.00
NHTC balance_sheet (annual, 2024-12-31) — Leases: 753000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Leases: 753000.00
NHTC balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1514000.00
NHTC balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1514000.00
NHTC balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1747000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1747000.00
NHTC income_statement (annual, 2024-12-31) — Net Income: 572000.00
NHTC income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 572000.00
NHTC income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 572000.00
NHTC income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 572000.00
NHTC income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 572000.00
NHTC cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 572000.00
NHTC income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 572000.00
NHTC cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -30018000.00
NHTC balance_sheet (annual, 2024-12-31) — Net PPE: 2688000.00
NHTC cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -57000.00
NHTC balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 32872000.00
NHTC balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 382000.00
NHTC balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 174000.00
NHTC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 382000.00
NHTC balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 174000.00
NHTC income_statement (annual, 2024-12-31) — Normalized EBITDA: -1168000.00
NHTC income_statement (annual, 2024-12-31) — Normalized Income: 572000.00
NHTC cash_flow (annual, 2024-12-31) — Operating Cash Flow: -3367000.00
NHTC income_statement (annual, 2024-12-31) — Operating Income: -1299000.00
NHTC income_statement (annual, 2024-12-31) — Operating Revenue: 43273000.00
NHTC balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 11513075.00
NHTC balance_sheet (annual, 2024-12-31) — Other Current Assets: 3771000.00
NHTC balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3995000.00
NHTC balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1301000.00
NHTC income_statement (annual, 2024-12-31) — Other Gand A: 15513000.00
NHTC income_statement (annual, 2024-12-31) — Other Income Expense: 1919000.00
NHTC cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1087000.00
NHTC balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1306000.00
NHTC income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1919000.00
NHTC balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 30407000.00
NHTC balance_sheet (annual, 2024-12-31) — Payables: 5803000.00
NHTC balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8508000.00
NHTC balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 656000.00
NHTC balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
NHTC income_statement (annual, 2024-12-31) — Pretax Income: 620000.00
NHTC balance_sheet (annual, 2024-12-31) — Properties: 0.00
NHTC balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
NHTC cash_flow (annual, 2024-12-31) — Purchase Of Investment: -70431000.00
NHTC cash_flow (annual, 2024-12-31) — Purchase Of PPE: -57000.00
NHTC balance_sheet (annual, 2024-12-31) — Raw Materials: 502000.00
NHTC income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 11178000.00
NHTC income_statement (annual, 2024-12-31) — Reconciled Depreciation: 131000.00
NHTC balance_sheet (annual, 2024-12-31) — Retained Earnings: -26344000.00
NHTC cash_flow (annual, 2024-12-31) — Sale Of Investment: 40413000.00
NHTC income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 17571000.00
NHTC income_statement (annual, 2024-12-31) — Selling General And Administration: 33084000.00
NHTC balance_sheet (annual, 2024-12-31) — Share Issued: 12979414.00
NHTC cash_flow (annual, 2024-12-31) — Stock Based Compensation: 145000.00
NHTC balance_sheet (annual, 2024-12-31) — Stockholders Equity: 32872000.00
NHTC balance_sheet (annual, 2024-12-31) — Tangible Book Value: 32872000.00
NHTC income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NHTC income_statement (annual, 2024-12-31) — Tax Provision: 48000.00
NHTC income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.08
NHTC balance_sheet (annual, 2024-12-31) — Total Assets: 55359000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Capitalization: 32872000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Debt: 2641000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 32872000.00
NHTC income_statement (annual, 2024-12-31) — Total Expenses: 44262000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 22487000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4376000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1688000.00
NHTC income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -1299000.00
NHTC balance_sheet (annual, 2024-12-31) — Total Tax Payable: 4908000.00
NHTC balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 4908000.00
NHTC balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
NHTC balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
NHTC balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1466339.00
NHTC balance_sheet (annual, 2024-12-31) — Treasury Stock: 24397000.00